logo
搜索
菜单

Pt的搜索结果

当前1/69页
排序: 最近更新
24.5: Chemotherapy-Induced Nausea and Vomiting: Cannabinoids 01:21 min
24.5: Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
24.4: Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists 01:29 min
24.4: Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
24.3: Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28 min
24.3: Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
24.2: Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists 01:27 min
24.2: Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
24.1: Pathophysiology of Vomiting 01:22 min
24.1: Pathophysiology of Vomiting
23.5: Drugs for Treatment of Crohn’s Disease in IBD Using Immunomodulatory Agents 01:29 min
23.5: Drugs for Treatment of Crohn’s Disease in IBD Using Immunomodulatory Agents
23.2: Drugs for Treatment of Diarrhea-Predominant IBS 01:17 min
23.2: Drugs for Treatment of Diarrhea-Predominant IBS
22.8: Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents 01:17 min
22.8: Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
22.5: Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists 01:23 min
22.5: Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
22.4: Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists 01:28 min
22.4: Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
22.3: Gastrointestinal Motility Disorders 01:20 min
22.3: Gastrointestinal Motility Disorders
22.2: Enteric Nervous System: Regulation of GI Motor Activity 01:11 min
22.2: Enteric Nervous System: Regulation of GI Motor Activity
22.1: Physiology of Enteric Nervous System and Gut Health 01:05 min
22.1: Physiology of Enteric Nervous System and Gut Health
21.8: Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy 01:16 min
21.8: Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
21.7: Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents 01:20 min
21.7: Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
21.6: Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents 01:24 min
21.6: Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
21.5: Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids 01:31 min
21.5: Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
21.4: Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists 01:28 min
21.4: Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
21.3: Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors 01:13 min
21.3: Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
21.2: Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors 01:24 min
21.2: Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
返回顶部